Skip to content

Clinical trials

Phase 2 Endometrial Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 2 Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20091
20111
20121
20141
20161
20171
20181
20191
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting2
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
AstraZeneca1
Daiichi Sankyo1
Gynecologic Oncology Group1
Institute of Cancer Research, United Kingdom1
Ipsen1
Millennium Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1
Pfizer1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms15
Ovarian Neoplasms5
Uterine Cervical Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Carcinosarcoma2
Esophageal Neoplasms2
Head and Neck Neoplasms2
Prostatic Neoplasms2
Stomach Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.